What the Research Says
Oral nitric-oxide precursor evidence must be separated from research on inhaled nitric oxide or nitric oxide measured as a disease biomarker. The latter studies do not establish benefits from taking an oral supplement.
Schwedhelm et al. studied 20 healthy volunteers in a randomized, placebo-controlled crossover trial. After one week, oral L-citrulline raised plasma L-arginine and some nitric-oxide signaling markers. No treatment significantly improved flow-mediated dilation, so improved biomarkers should not be presented as proof of improved vascular function in that trial. [1]
Trexler et al. pooled 12 studies with 13 independent samples (198 participants). Citrulline produced a small effect on high-intensity strength and power outcomes (standardized mean difference 0.20; 95% CI 0.01-0.39). Each individual study's confidence interval included no effect. This analysis does not establish broad endurance, time-to-exhaustion, or recovery benefits. [2]
Siervo et al. included 16 crossover trials with 254 participants. Inorganic nitrate or beetroot juice reduced systolic blood pressure by an average 4.4 mm Hg versus placebo (95% CI -5.9 to -2.8); the diastolic change was not statistically significant. Interventions lasted only two hours to 15 days, limiting conclusions about sustained benefit. [3]
These findings are specific to the tested precursor, dose, population, and outcome; they do not validate every commercial NO-booster blend. Mechanistic and preliminary findings should not be treated as established clinical benefits. [1, 2, 3, 11]



